世界の早期陣痛治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preterm Labor Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4784
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、早期陣痛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（子宮収縮抑制薬、ベータ模倣薬、カルシウムチャネル遮断薬、NSAID、コルチコステロイド、硫酸マグネシウム、抗生物質）、用途別市場規模（病院、小児科＆新生児クリニック、ナーシングホーム、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・早期陣痛治療の市場動向
・企業の競争状況、市場シェア
・早期陣痛治療の種類別市場規模（子宮収縮抑制薬、ベータ模倣薬、カルシウムチャネル遮断薬、NSAID、コルチコステロイド、硫酸マグネシウム、抗生物質）
・早期陣痛治療の用途別市場規模（病院、小児科＆新生児クリニック、ナーシングホーム、薬局）
・早期陣痛治療の北米市場規模2016-2027（アメリカ、カナダ）
・早期陣痛治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・早期陣痛治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・早期陣痛治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・早期陣痛治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、Merck、Sanofi、Johnson and Johnson、GSK、AstraZeneca、Cipla）
・結論

Market Analysis and Insights: Global Preterm Labor Treatment Market
The global Preterm Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preterm Labor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preterm Labor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preterm Labor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preterm Labor Treatment market.

Global Preterm Labor Treatment Scope and Market Size
Preterm Labor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preterm Labor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tocolytic Drugs
Beta – Mimetic
Calcium Channel Blockers
NSAIDS
Corticosteroids
Magnesium Sulphate
Antibiotics

Segment by Application
Hospitals
Pediatric and Neonatal Clinics
Nursing Homes
Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Cipla

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preterm Labor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tocolytic Drugs
1.2.3 Beta – Mimetic
1.2.4 Calcium Channel Blockers
1.2.5 NSAIDS
1.2.6 Corticosteroids
1.2.7 Magnesium Sulphate
1.2.8 Antibiotics
1.3 Market by Application
1.3.1 Global Preterm Labor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pediatric and Neonatal Clinics
1.3.4 Nursing Homes
1.3.5 Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preterm Labor Treatment Market Perspective (2016-2027)
2.2 Preterm Labor Treatment Growth Trends by Regions
2.2.1 Preterm Labor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preterm Labor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Preterm Labor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Preterm Labor Treatment Industry Dynamic
2.3.1 Preterm Labor Treatment Market Trends
2.3.2 Preterm Labor Treatment Market Drivers
2.3.3 Preterm Labor Treatment Market Challenges
2.3.4 Preterm Labor Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preterm Labor Treatment Players by Revenue
3.1.1 Global Top Preterm Labor Treatment Players by Revenue (2016-2021)
3.1.2 Global Preterm Labor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Preterm Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preterm Labor Treatment Revenue
3.4 Global Preterm Labor Treatment Market Concentration Ratio
3.4.1 Global Preterm Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preterm Labor Treatment Revenue in 2020
3.5 Preterm Labor Treatment Key Players Head office and Area Served
3.6 Key Players Preterm Labor Treatment Product Solution and Service
3.7 Date of Enter into Preterm Labor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preterm Labor Treatment Breakdown Data by Type
4.1 Global Preterm Labor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Preterm Labor Treatment Forecasted Market Size by Type (2022-2027)

5 Preterm Labor Treatment Breakdown Data by Application
5.1 Global Preterm Labor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Preterm Labor Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preterm Labor Treatment Market Size (2016-2027)
6.2 North America Preterm Labor Treatment Market Size by Type
6.2.1 North America Preterm Labor Treatment Market Size by Type (2016-2021)
6.2.2 North America Preterm Labor Treatment Market Size by Type (2022-2027)
6.2.3 North America Preterm Labor Treatment Market Size by Type (2016-2027)
6.3 North America Preterm Labor Treatment Market Size by Application
6.3.1 North America Preterm Labor Treatment Market Size by Application (2016-2021)
6.3.2 North America Preterm Labor Treatment Market Size by Application (2022-2027)
6.3.3 North America Preterm Labor Treatment Market Size by Application (2016-2027)
6.4 North America Preterm Labor Treatment Market Size by Country
6.4.1 North America Preterm Labor Treatment Market Size by Country (2016-2021)
6.4.2 North America Preterm Labor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Preterm Labor Treatment Market Size (2016-2027)
7.2 Europe Preterm Labor Treatment Market Size by Type
7.2.1 Europe Preterm Labor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Preterm Labor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Preterm Labor Treatment Market Size by Type (2016-2027)
7.3 Europe Preterm Labor Treatment Market Size by Application
7.3.1 Europe Preterm Labor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Preterm Labor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Preterm Labor Treatment Market Size by Application (2016-2027)
7.4 Europe Preterm Labor Treatment Market Size by Country
7.4.1 Europe Preterm Labor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Preterm Labor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preterm Labor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Preterm Labor Treatment Market Size by Type
8.2.1 Asia-Pacific Preterm Labor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preterm Labor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preterm Labor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Preterm Labor Treatment Market Size by Application
8.3.1 Asia-Pacific Preterm Labor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preterm Labor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preterm Labor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Preterm Labor Treatment Market Size by Region
8.4.1 Asia-Pacific Preterm Labor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preterm Labor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preterm Labor Treatment Market Size (2016-2027)
9.2 Latin America Preterm Labor Treatment Market Size by Type
9.2.1 Latin America Preterm Labor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Preterm Labor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Preterm Labor Treatment Market Size by Type (2016-2027)
9.3 Latin America Preterm Labor Treatment Market Size by Application
9.3.1 Latin America Preterm Labor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Preterm Labor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Preterm Labor Treatment Market Size by Application (2016-2027)
9.4 Latin America Preterm Labor Treatment Market Size by Country
9.4.1 Latin America Preterm Labor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Preterm Labor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preterm Labor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Preterm Labor Treatment Market Size by Type
10.2.1 Middle East & Africa Preterm Labor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preterm Labor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preterm Labor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Preterm Labor Treatment Market Size by Application
10.3.1 Middle East & Africa Preterm Labor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preterm Labor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preterm Labor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Preterm Labor Treatment Market Size by Country
10.4.1 Middle East & Africa Preterm Labor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preterm Labor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Preterm Labor Treatment Introduction
11.1.4 Pfizer Revenue in Preterm Labor Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Preterm Labor Treatment Introduction
11.2.4 Novartis Revenue in Preterm Labor Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Preterm Labor Treatment Introduction
11.3.4 Merck Revenue in Preterm Labor Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Preterm Labor Treatment Introduction
11.4.4 Sanofi Revenue in Preterm Labor Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Details
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Preterm Labor Treatment Introduction
11.5.4 Johnson and Johnson Revenue in Preterm Labor Treatment Business (2016-2021)
11.5.5 Johnson and Johnson Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Preterm Labor Treatment Introduction
11.6.4 GSK Revenue in Preterm Labor Treatment Business (2016-2021)
11.6.5 GSK Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Preterm Labor Treatment Introduction
11.7.4 AstraZeneca Revenue in Preterm Labor Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Cipla
11.8.1 Cipla Company Details
11.8.2 Cipla Business Overview
11.8.3 Cipla Preterm Labor Treatment Introduction
11.8.4 Cipla Revenue in Preterm Labor Treatment Business (2016-2021)
11.8.5 Cipla Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preterm Labor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tocolytic Drugs
Table 3. Key Players of Beta – Mimetic
Table 4. Key Players of Calcium Channel Blockers
Table 5. Key Players of NSAIDS
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Magnesium Sulphate
Table 8. Key Players of Antibiotics
Table 9. Global Preterm Labor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Preterm Labor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Preterm Labor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Preterm Labor Treatment Market Share by Regions (2016-2021)
Table 13. Global Preterm Labor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Preterm Labor Treatment Market Share by Regions (2022-2027)
Table 15. Preterm Labor Treatment Market Trends
Table 16. Preterm Labor Treatment Market Drivers
Table 17. Preterm Labor Treatment Market Challenges
Table 18. Preterm Labor Treatment Market Restraints
Table 19. Global Preterm Labor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Preterm Labor Treatment Market Share by Players (2016-2021)
Table 21. Global Top Preterm Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preterm Labor Treatment as of 2020)
Table 22. Ranking of Global Top Preterm Labor Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Preterm Labor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Preterm Labor Treatment Product Solution and Service
Table 26. Date of Enter into Preterm Labor Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Preterm Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Preterm Labor Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Preterm Labor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Preterm Labor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Preterm Labor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Preterm Labor Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Preterm Labor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Preterm Labor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Preterm Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Preterm Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Preterm Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Preterm Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Preterm Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Preterm Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Preterm Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Preterm Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Preterm Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Preterm Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Preterm Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Preterm Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Preterm Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Preterm Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Preterm Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Preterm Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Preterm Labor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Preterm Labor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Preterm Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Preterm Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Preterm Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Preterm Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Preterm Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Preterm Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Preterm Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Preterm Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Preterm Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Preterm Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Preterm Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Preterm Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Preterm Labor Treatment Product
Table 69. Pfizer Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Preterm Labor Treatment Product
Table 74. Novartis Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Preterm Labor Treatment Product
Table 79. Merck Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Preterm Labor Treatment Product
Table 84. Sanofi Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Johnson and Johnson Company Details
Table 87. Johnson and Johnson Business Overview
Table 88. Johnson and Johnson Preterm Labor Treatment Product
Table 89. Johnson and Johnson Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 90. Johnson and Johnson Recent Development
Table 91. GSK Company Details
Table 92. GSK Business Overview
Table 93. GSK Preterm Labor Treatment Product
Table 94. GSK Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 95. GSK Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Preterm Labor Treatment Product
Table 99. AstraZeneca Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Cipla Company Details
Table 102. Cipla Business Overview
Table 103. Cipla Revenue in Preterm Labor Treatment Business (2016-2021) & (US$ Million)
Table 104. Cipla Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preterm Labor Treatment Market Share by Type: 2020 VS 2027
Figure 2. Tocolytic Drugs Features
Figure 3. Beta – Mimetic Features
Figure 4. Calcium Channel Blockers Features
Figure 5. NSAIDS Features
Figure 6. Corticosteroids Features
Figure 7. Magnesium Sulphate Features
Figure 8. Antibiotics Features
Figure 9. Global Preterm Labor Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Pediatric and Neonatal Clinics Case Studies
Figure 12. Nursing Homes Case Studies
Figure 13. Pharmacy Case Studies
Figure 14. Preterm Labor Treatment Report Years Considered
Figure 15. Global Preterm Labor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Preterm Labor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Preterm Labor Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Preterm Labor Treatment Market Share by Regions (2022-2027)
Figure 19. Global Preterm Labor Treatment Market Share by Players in 2020
Figure 20. Global Top Preterm Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preterm Labor Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Preterm Labor Treatment Revenue in 2020
Figure 22. Global Preterm Labor Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Preterm Labor Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Preterm Labor Treatment Market Share by Type (2016-2027)
Figure 26. North America Preterm Labor Treatment Market Share by Application (2016-2027)
Figure 27. North America Preterm Labor Treatment Market Share by Country (2016-2027)
Figure 28. United States Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Preterm Labor Treatment Market Share by Type (2016-2027)
Figure 32. Europe Preterm Labor Treatment Market Share by Application (2016-2027)
Figure 33. Europe Preterm Labor Treatment Market Share by Country (2016-2027)
Figure 34. Germany Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Preterm Labor Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Preterm Labor Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Preterm Labor Treatment Market Share by Region (2016-2027)
Figure 44. China Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Preterm Labor Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Preterm Labor Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Preterm Labor Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Preterm Labor Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Preterm Labor Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Preterm Labor Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Preterm Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 67. Johnson and Johnson Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 70. Cipla Revenue Growth Rate in Preterm Labor Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の早産治療市場規模・現状・予測（2021年-2027年）

Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4769 2021年4月 93Pages
QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の早産管理市場規模・現状・予測（2021年-2027年）

Global Preterm Birth Control Market Size, Status and Forecast 2021-2027
QYR2104Z4783 2021年4月 99Pages
QYResearch社発行の本調査資料では、早産管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、薬物治療）、用途別市場規模（病院、不妊治療クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の早産治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Premature Labor Treatment Market The global Premature Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
世界の早産管理市場規模・現状・予測（2021年-2027年） Preterm birth is defined as babies born alive before 37 weeks of pregnancy completion. According to the World Health Organization (WHO), approximately 15 million babies that are victims of preterm birth every years. The identification of women with high risk of preterm birth is a major challenge til…
世界の胎児（陣痛＆分娩）・新生児ケア用機器市場 2021：企業別、地域別、種類・用途別 The Fetal (Labor & Delivery) And Neonatal Care Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
世界の小児神経芽細胞腫治療市場規模・現状・予測（2021年-2027年） In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market size is…
世界の胃炎治療薬市場規模・現状・予測（2021年-2027年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …